Skip to main content
DNA Labs India

EARS2 Gene Combined oxidative phosphorylation deficiency type 12 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

EARS2 Gene Combined oxidative phosphorylation deficiency type 12 NGS Genetic Test

Short Name: EARS2 Gene COXPD Type 12 NGS Test

Also known as: EARS2 Gene Mutation Test, COXPD Type 12 Genetic Test, Mitochondrial Glutamyl-tRNA Synthetase Deficiency Test, EARS2 NGS Panel, Combined Oxidative Phosphorylation Deficiency 12 DNA Test

EARS2 Gene Combined oxidative phosphorylation deficiency type 12 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS), Sanger Confirmation of Pathogenic Variants, Bioinformatics Variant Annotation on Blood or Extracted DNA or One Drop Blood on FTA Card samples. Results in Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Urgent cases may be accommodated upon prior arrangement with the laboratory.. Free home collection in 300+ cities across India.

Next Generation Sequencing (NGS)All Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the EARS2 Gene COXPD Type 12 NGS Genetic Test is to identify pathogenic mutations in the EARS2 gene responsible for combined oxidative phosphorylation deficiency type 12. This test enables confirmation of clinical diagnosis in symptomatic individuals, guides metabolic and supportive treatment decisions, facilitates carrier testing for family members, and assists in reproductive planning and prenatal diagnosis for at-risk families. It is also valuable for differentiating COXPD12 from other mitochondrial and metabolic disorders presenting with similar clinical features.

Test Code
1937
CPT Code
81479
ICD Code
E88.89
Price
₹20,000
Sample Type
Blood or Extracted DNA or One Drop Blood on FTA Card
Result Time
Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Urgent cases may be accommodated upon prior arrangement with the laboratory.
Fasting Required
No
Method
Next Generation Sequencing (NGS), Sanger Confirmation of Pathogenic Variants, Bioinformatics Variant Annotation
Step 1

Sample Collection

No fasting is required. Provide complete clinical history and pedigree information of affected family members. A pre-test genetic counselling session is strongly recommended. Avoid blood transfusions for at least 4 weeks before sample collection.

Method: Venipuncture or FTA card finger-prick

Step 2

Laboratory Analysis

A trained phlebotomist will collect 3-5 mL of peripheral venous blood in an EDTA (lavender-top) vacutainer. Alternatively, one drop of blood on an FTA card or an extracted DNA sample may be submitted. The procedure takes approximately 5-10 minutes.

Step 3

Report Delivery

The sample is labelled, stored at ambient room temperature, and transported to the DNA Labs India laboratory under controlled conditions. No post-collection restrictions are required. Results are delivered within 3 to 4 weeks via the online portal, email, or WhatsApp.

Timeline: Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Urgent cases may be accommodated upon prior arrangement with the laboratory.

Patient Instructions

1
Before the Test:No special preparation or fasting is required before sample collection. A pre-test genetic counselling session is recommended to discuss the implications of the test, obtain informed consent, and document the family pedigree. Provide the laboratory with complete clinical history, relevant neuroimaging reports, and metabolic investigation results.
2
During the Test:A simple venous blood draw (3-5 mL in an EDTA tube) is performed by a trained phlebotomist. The entire collection process takes approximately 5-10 minutes. Free home sample collection is available across India through DNA Labs India.
3
After the Test:After blood collection, there are no activity restrictions. Apply gentle pressure to the puncture site for a few minutes. The sample is transported to the laboratory for NGS analysis. Results are typically available within 3 to 4 weeks and are delivered via the online portal, email, or WhatsApp.

About This Test

Who Should Get This Test

The purpose of the EARS2 Gene COXPD Type 12 NGS Genetic Test is to identify pathogenic mutations in the EARS2 gene responsible for combined oxidative phosphorylation deficiency type 12. This test enables confirmation of clinical diagnosis in symptomatic individuals, guides metabolic and supportive treatment decisions, facilitates carrier testing for family members, and assists in reproductive planning and prenatal diagnosis for at-risk families. It is also valuable for differentiating COXPD12 from other mitochondrial and metabolic disorders presenting with similar clinical features.

How to Prepare

  • Use an EDTA (lavender-top) vacutainer for blood collection.
  • Do not use heparin tubes, as heparin can interfere with downstream molecular assays.
  • Label the sample clearly with patient name, date of birth, and unique identification number.
  • If using an FTA card, ensure one complete blood drop saturates the designated area and allow it to dry completely.
  • Store the sample at ambient room temperature (15-30°C) and transport within 48 hours of collection.
  • Free home sample collection is available across India for online bookings.

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"COXPD type 12 is an ultra-rare mitochondrial disorder caused by biallelic mutations in the EARS2 gene. Early genetic confirmation through NGS allows accurate diagnosis, appropriate metabolic management, genetic counselling for families, and informed reproductive planning. I recommend this test for any infant or child presenting with unexplained leukoencephalopathy, lactic acidosis, hypotonia, or developmental regression, particularly when mitochondrial disease is suspected. Timely diagnosis can guide supportive care and prevent unnecessary investigations."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One Drop Blood on FTA Card
Sample Volume3-5 mL peripheral blood in EDTA tube
ContainerEDTA (Lavender Top) Vacutainer or FTA Card
Collection MethodVenipuncture or FTA card finger-prick

Sample Stability

EDTA Blood at Ambient Temperature (15-30°C)
EDTA Blood at 2-8°C (Refrigerated)
Extracted DNA at -20°C
FTA Card (Dried Blood Spot)
Sample Rejection Criteria:
  • Sample collected in heparin anticoagulant tube
  • Haemolysed or visibly contaminated blood sample
  • Insufficient sample volume (less than 1 mL for blood)
  • Unlabelled or mislabelled samples
  • Sample collected more than 7 days prior without refrigeration
  • DNA sample with A260/A280 ratio outside 1.7-2.0 range

Understanding Your Results

The results of the EARS2 Gene COXPD Type 12 NGS Genetic Test are interpreted in the context of the patient's clinical presentation, family history, and ancillary investigations including metabolic and neuroimaging findings. A report will indicate whether pathogenic, likely pathogenic, or variants of uncertain significance were identified in the EARS2 gene. Genetic counselling is essential for proper interpretation and family planning guidance.
📊

No pathogenic or likely pathogenic variants were identified in the EARS2 gene. This result does not entirely exclude COXPD12 if clinical suspicion remains high; other mitochondrial or nuclear genes may be involved. Further clinical evaluation and additional genetic testing may be considered.

📊

A homozygous pathogenic variant was identified in the EARS2 gene, consistent with a diagnosis of COXPD type 12. Both parents are expected to be carriers. Genetic counselling and carrier testing for family members is recommended.

📊

Two different pathogenic or likely pathogenic variants were identified in the EARS2 gene on opposite alleles, consistent with a diagnosis of COXPD type 12. Each parent is expected to carry one variant. Carrier testing for family members and reproductive counselling is recommended.

📊

A single pathogenic variant was detected in the EARS2 gene. The individual is likely a carrier of COXPD type 12 and is typically unaffected. Carrier testing of the partner is recommended for reproductive planning.

📊

A variant of uncertain significance was identified. Current evidence is insufficient to classify this variant as pathogenic or benign. Familial segregation analysis, functional studies, and periodic re-evaluation as new data become available are recommended. Clinical correlation is essential.

⚠️ When to Consult a Doctor:

Consult a geneticist or metabolic specialist if your child presents with unexplained developmental delay, hypotonia, seizures, feeding difficulties, lactic acidosis, or neurological regression. If the test result identifies a pathogenic variant or a variant of uncertain significance, seek genetic counselling for interpretation, family screening, and reproductive planning. Early consultation allows timely supportive management and may prevent unnecessary diagnostic investigations.

Limitations

  • This test does not detect large genomic rearrangements, copy number variations, or deep intronic mutations beyond flanking splice sites unless specifically included.
  • Variants of uncertain significance may be identified and may require further familial segregation studies or functional analysis.
  • A negative result does not completely exclude mitochondrial disease, as other genes or mitochondrial DNA variants may be causative.
  • Results should always be interpreted in conjunction with clinical presentation, biochemical findings, and neuroimaging by a qualified geneticist or metabolic specialist.
  • This test is not validated for prenatal diagnosis from chorionic villus sampling or amniotic fluid without prior validation.

Risks & Considerations

  • Minor bruising or discomfort at the venipuncture site
  • Very rare risk of infection at the blood draw site
  • No significant medical risks associated with the blood collection procedure
  • Emotional impact of genetic results; genetic counselling is recommended before and after testing

Interfering Factors

  • Degraded or insufficient DNA quality in the submitted sample
  • Recent blood transfusion within the past 4 weeks may affect variant detection
  • Sample contamination during collection or transport
  • Heparin-based anticoagulant in the sample tube (EDTA is preferred)

Compare With Similar Tests

TestEARS2 Gene Combined oxidative phosphorylation deficiency type 12 NGS Genetic TestSingle Gene Sanger SequencingMitochondrial DNA SequencingBiochemical Enzyme Assay
ComparisonEARS2 Gene Combined oxidative phosphorylation deficiency type 12 NGS Genetic Test

Frequently Asked Questions

What is the EARS2 Gene COXPD Type 12 NGS Genetic Test?
This is a next-generation sequencing (NGS) based genetic test that analyses the EARS2 gene for mutations responsible for combined oxidative phosphorylation deficiency type 12 (COXPD12), a rare mitochondrial disorder. It provides a definitive molecular diagnosis by identifying pathogenic variants in the gene.
What is COXPD Type 12 and how does it affect the body?
Combined oxidative phosphorylation deficiency type 12 is a rare autosomal recessive disorder caused by mutations in the EARS2 gene. The gene encodes mitochondrial glutamyl-tRNA synthetase, essential for mitochondrial protein synthesis. Dysfunction leads to impaired energy production, primarily affecting the brain, muscles, and other energy-demanding organs, causing symptoms such as developmental delay, hypotonia, seizures, and leukoencephalopathy.
Who should get the EARS2 Gene NGS Genetic Test?
This test is recommended for individuals suspected of having COXPD type 12, including infants or children with unexplained developmental delay, hypotonia, seizures, lactic acidosis, leukoencephalopathy, or encephalopathy. It is also recommended for carrier testing in parents and siblings of confirmed cases, and for families planning future pregnancies.
What sample is required for this genetic test?
The test requires a blood sample (3-5 mL in an EDTA vacutainer), an extracted DNA sample, or one drop of blood on an FTA card. No fasting is required. Free home sample collection is available across India.
How long does it take to get the results?
Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Reports are delivered via the online portal, email, or WhatsApp.
What does a negative test result mean?
A negative result means no pathogenic or likely pathogenic variants were identified in the EARS2 gene. However, this does not entirely exclude mitochondrial disease, as other genes (nuclear or mitochondrial DNA) may be causative. Further clinical evaluation and additional genetic testing may be recommended by your geneticist.
What is a Variant of Uncertain Significance (VUS)?
A VUS is a genetic variant for which there is insufficient evidence to classify it as definitively pathogenic or benign. If a VUS is found, your geneticist may recommend periodic re-evaluation, familial segregation analysis, or functional studies to clarify its significance as new scientific evidence becomes available.
Is genetic counselling required before taking this test?
Yes, a pre-test genetic counselling session is strongly recommended. A genetic counsellor or clinical geneticist will explain the test purpose, potential outcomes, implications for family members, limitations, and obtain informed consent. A post-test counselling session is also advised to discuss the results.
What is the cost of the EARS2 Gene NGS Genetic Test?
The EARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 12 NGS Genetic Test costs INR 20,000 at DNA Labs India. This price includes free home sample collection, NGS analysis, bioinformatics interpretation, and digital report delivery.
Can this test be used for prenatal diagnosis?
This test is primarily validated for postnatal diagnostic use from peripheral blood or extracted DNA. Prenatal diagnosis from chorionic villus sampling (CVS) or amniotic fluid requires prior validation and specific arrangement with the laboratory. Consult your geneticist and the laboratory for prenatal testing options.
Is this test available for home sample collection?
Yes, DNA Labs India offers free home sample collection for the EARS2 Gene NGS Genetic Test for online bookings across India. This service is available in all major cities and towns. A trained phlebotomist will visit your location to collect the sample.
How accurate is the NGS Genetic Test for detecting EARS2 mutations?
Next-generation sequencing technology provides high sensitivity and specificity for detecting point mutations, small insertions, and deletions in the EARS2 gene, with coverage of ?99% of coding exons and flanking intronic regions at ?20x depth. Pathogenic variants are confirmed using Sanger sequencing. However, certain types of mutations such as large rearrangements or deep intronic variants may not be detected by this method.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.